The 2020 Worldwide Pharma & Biotech Industry R&D Scene
Infographic Of R&D KPIs
INFOGRAPHIC: A snapshot of the industry in key performance indicators, taken in early 2020.
You may also be interested in...
Join us for a quick audio roundup of five useful things to know from Scrip’s recent coverage of the global biopharmaceutical industry.
Positive Phase II data for Aptinyx’s novel NMDA receptor modulator are strong enough to take the product into a pivotal study in this difficult-to-treat area.
Orchard Therapeutics is on the cusp of the first approval for its ex vivo gene therapy, Libmeldy, for metachromatic leukodystrophy.